– Congruence has been awarded the Neuroscience Section Blitz Talk Award for transformative research in MC4R-related early-onset genetic obesity – – Congruence’s insights into the biology and pharmacology of MC4R deficiency and its proprietary drug discovery engine, Revenir™, identified…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.